JORDI MAYNERIS PERXACHS

Jordi Mayneris Perxachs is a Group Leader (R4) at the Institute for Biomedical Research of Girona (IDIBGI) affiliated with the University of Girona. His research focuses on the gut microbiome’s role in metabolic and cognitive disorders, including obesity, neurodegeneration, and Alzheimer’s disease. He leads projects funded by institutions like the Institute of Health Carlos III and the AXA Foundation, investigating microbiome-brain interactions, metabolic crosstalk, and precision medicine.

Research Interests: His work integrates systems biology, metabolomics, and clinical studies to explore how gut microbial metabolites influence cognition, metabolic health, and aging. Key areas include archaea methanogens’ effects on cognitive performance, microbiome-driven food addiction mechanisms, and the microbiota’s role in modulating antiviral responses.

Publications: Recent studies highlight associations between gut microbiota composition and cognitive decline, metformin’s effects on microbiome-cognition links, and the discovery of microviridae phages influencing food addiction. His work bridges basic science and clinical applications, emphasizing translational research.

Awards: He received the Constantes y Vitales Award for Young Talent in Biomedical Research (2024-2025) from AXA Seguros Generales SA, recognizing his contributions to microbiome-cognition research.

Grants & Teams: Leads multiple grants totaling millions in funding, including projects on MAFLD precision medicine, microbiota-brain cross-talk, and Alzheimer’s-related microbiome studies. Collaborates with institutions like the Institute of Bioengineering of Catalonia and the University of Barcelona.